Vis enkel innførsel

dc.contributor.authorÅrdal, Christine Oline
dc.contributor.authorBaraldi, Enrico
dc.contributor.authorTheuretzbacher, Ursula
dc.contributor.authorOutterson, Kevin
dc.contributor.authorPlahte, Jens
dc.contributor.authorCiabuschi, Francesco
dc.contributor.authorRøttingen, John-Arne
dc.date.accessioned2021-05-28T10:22:15Z
dc.date.available2021-05-28T10:22:15Z
dc.date.created2018-07-03T11:47:19Z
dc.date.issued2018
dc.identifier.citationJournal of Pharmaceutical Policy and Practice. 2018, 11 .
dc.identifier.issn2052-3211
dc.identifier.urihttps://hdl.handle.net/11250/2756840
dc.language.isoeng
dc.relation.urihttps://joppp.biomedcentral.com/track/pdf/10.1186/s40545-018-0135-0
dc.titleInsights into early stage of antibiotic development in small- and medium-sized enterprises: A survey of targets, costs, and durations
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber10
dc.source.volume11
dc.source.journalJournal of Pharmaceutical Policy and Practice
dc.identifier.doi10.1186/s40545-018-0135-0
dc.identifier.cristin1595394
cristin.unitcode7502,4,13,0
cristin.unitcode7502,0,0,0
cristin.unitnameAvdeling for resistens- og infeksjonsforebygging
cristin.unitnameFolkehelseinstituttet
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel